GLP-1 receptor agonists and recovery results after neck spine fusion surgery: a review and analysis of real-world data

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may influence outcomes after cervical spine fusion.

• GLP-1RAs are commonly prescribed for managing type 2 diabetes and obesity.
• The effects of GLP-1RAs on recovery and overall outcomes following cervical spine fusion are not well understood.
• Further investigation is needed to clarify the relationship between GLP-1RA use and surgical outcomes in this context.

Simplified